MVP-12.01: Robotic Salvage Partial Nephrectomy and Vena Cava Thrombectomy on a Horseshoe Kidney
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.01: A Propensity Matched Cohort Study Evaluating Long-Term Oncologic Outcomes in Patients who Underwent Percutaneous Microwave Ablation vs Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma.
Presenting Author: Ilias Giannakodimos – Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.02: Are Benign Kidney Tumour Resections Avoidable? a Tertiary Care Center Experience over Decade
Presenting Author: Ravimohan S. Mavuduru – Post Graduate Institute of Medical Education and Research
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.03: Enhancing Postoperative Care: Implementation of Telemonitoring in Robot-Assisted Partial Nephrectomy (UroCCR N°229)
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.04: Molecular Correlates of Clinical Response to Combination Immunotherapy in Advanced Fumarate Hydratase Deficient Renal Cell Carcinoma
Presenting Author: Yunze Xu – Renji Hospital, Shanghai Jiao Tong University School of Medicine
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.05: Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models: Internal and External Validation
Presenting Author: Lucia Puig – Asan Medical Center
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.06: Preoperative Role of Systemic Immune Indices in the Differential Diagnosis Between Chromophobe Renal Cell Carcinoma and Oncocytoma
Kidney and Ureteral Cancer - Clinical
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-12.07: Recurrence-Free Survival and Upstaging Risk Following Biopsy in T1 RCC: a Large Single-Center Propensity Score-Matched Analysis
